Oba, T., Long, M. D., Keler, T., Marsh, H. C., Minderman, H., Abrams, S. I., . . . Ito, F. (2020). Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s. Nature Portfolio.
Cita Chicago Style (17a ed.)Oba, Takaaki, Mark D. Long, Tibor Keler, Henry C. Marsh, Hans Minderman, Scott I. Abrams, Song Liu, y Fumito Ito. Overcoming Primary and Acquired Resistance to Anti-PD-L1 Therapy by Induction and Activation of Tumor-residing CDC1s. Nature Portfolio, 2020.
Cita MLA (8a ed.)Oba, Takaaki, et al. Overcoming Primary and Acquired Resistance to Anti-PD-L1 Therapy by Induction and Activation of Tumor-residing CDC1s. Nature Portfolio, 2020.
Precaución: Estas citas no son 100% exactas.